TipRanks
ImageneBio (IMA)
NASDAQ:IMA
US Market
IMA
ImageneBio
RESEARCH TOOLSreports
Want to see IMA full AI Analyst Report?

ImageneBio (IMA) Income Statement

115 Followers

ImageneBio Income Statement

Last quarter (Q2 2026), ImageneBio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, ImageneBio's net income was $-10.18M. See ImageneBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 800.00K$ 3.50M$ 9.16M$ 15.62M$ 30.98M
Gross Profit
$ -233.00K$ 1.97M$ 8.14M$ -48.70M$ -16.12M
Operating Expenses
$ 48.22M$ 38.97M$ 83.56M$ 22.20M$ 18.02M
Depreciation and Amortization
$ 1.03M$ 1.53M$ 1.02M$ 751.00K$ 544.00K
EBITDA
$ -44.67M$ -35.03M$ -67.31M$ -68.01M$ -33.57M
Operating Income
$ -48.45M$ -37.00M$ -75.42M$ -70.90M$ -34.14M
Other Income/Expenses
$ 2.75M$ 445.00K$ 7.09M$ 2.14M$ 23.00K
Pretax Income
$ -45.70M$ -36.55M$ -68.33M$ -68.77M$ -34.12M
Net Income
$ -45.35M$ -36.57M$ -68.17M$ -68.77M$ -34.12M
Per Share Metrics
Basic EPS
$ -9.64$ -40.52$ -19.60$ -22.80$ -11.38
Diluted EPS
$ -9.64$ -40.52$ -19.60$ -22.80$ -11.38
Weighted Average Shares Outstanding
 5.43M 1.19M 3.48M 3.02M 3.00M
Weighted Average Shares Outstanding (Diluted)
 5.43M 1.19M 3.48M 3.02M 3.00M
Currency in USD

ImageneBio Earnings and Revenue History